Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,126 | -12,670 | -5,919 | -19,832 | -16,529 |
| Depreciation Amortization | 883 | 609 | 315 | 939 | 645 |
| Accounts receivable | -23 | -15 | -1 | -7 | N/A |
| Other Working Capital | 934 | 510 | 116 | -13 | -189 |
| Other Operating Activity | 7,106 | 6,441 | 2,777 | 8,321 | 7,958 |
| Operating Cash Flow | $-8,226 | $-5,125 | $-2,713 | $-10,592 | $-8,116 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -15,008 | -15,000 | -15,000 | N/A | N/A |
| PPE Investments | -172 | -145 | -111 | -125 | -119 |
| Other Investing Activity | -308 | -248 | -112 | -412 | -326 |
| Investing Cash Flow | $-15,488 | $-15,393 | $-15,223 | $-537 | $-445 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 7,551 | 7,551 |
| Debt Repayment | -1,917 | -1,425 | -746 | N/A | N/A |
| Common Stock Issued | 21,263 | 20,838 | 20,606 | 13,157 | 10,078 |
| Other Financing Activity | -531 | -508 | -426 | -183 | -116 |
| Financing Cash Flow | $18,814 | $18,905 | $19,434 | $20,525 | $17,513 |
| Exchange Rate Effect | -1 | -1 | -1 | 6 | 5 |
| Beginning Cash Position | 16,846 | 16,846 | 16,846 | 7,444 | 7,444 |
| End Cash Position | 11,945 | 15,233 | 18,343 | 16,846 | 16,402 |
| Net Cash Flow | $-4,901 | $-1,614 | $1,497 | $9,402 | $8,958 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,226 | -5,125 | -2,713 | -10,592 | -8,116 |
| Capital Expenditure | -172 | -145 | -111 | -125 | -119 |
| Free Cash Flow | -8,399 | -5,270 | -2,824 | -10,717 | -8,235 |